Literature DB >> 22858173

[Evaluation of the Sysmex UF-1000i automated system for the diagnosis of urinary tract infection].

María Muñoz-Algarra1, Rocío Martínez-Ruiz, Beatriz Orden-Martínez.   

Abstract

OBJECTIVE: To evaluate the Sysmex UF-1000i system as a urine screening method for the diagnosis of urinary tract infection, and epithelial cells as a predictive value of contamination in woman of childbearing age.
METHODS: A total of 1730 urine samples were processed using a urine culture as a reference.
RESULTS: With 50 bacteria/μl as a cut-off point, the results were: sensitivity 91.3%, specificity 73.1%, negative predictive value 96.2%. For a specificity of 90% for epithelial cells, the results were: sensitivity 31.0%, positive predictive value 67.0%, negative predictive value 66.0%.
CONCLUSION: The evaluated system is fast and effective. Epithelial cells could be used to predict contamination.
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22858173     DOI: 10.1016/j.eimc.2012.05.017

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  3 in total

1.  Validation and Search of the Ideal Cut-Off of the Sysmex UF-1000i® Flow Cytometer for the Diagnosis of Urinary Tract Infection in a Tertiary Hospital in Spain.

Authors:  María I Millán-Lou; Juan M García-Lechuz; María A Ruiz-Andrés; Concepción López; María J Aldea; María J Revillo; Antonio Rezusta
Journal:  Front Med (Lausanne)       Date:  2018-04-09

2.  [Evaluation of Sysmex UF-1000i® flow cytometer as a screening method for asymptomatic bacteriuria and detection of Group B Streptococcus in pregnancy].

Authors:  I Angulo López; M Urrutikoetxea-Gutiérrez; J Aragón-Díez; M Fraca Padilla; J L Díaz de Tuesta Del Arco
Journal:  Rev Esp Quimioter       Date:  2020-05-11       Impact factor: 1.553

3.  [URISCAM project: Multicenter evaluation of the UF-Series cytometer in the urinary tract infections screening].

Authors:  M M Jarabo; M A Asencio; R Carranza; O Herráez; M Huertas; A Arias-Arias; O Redondo; M A Galán; M S Illescas; P Zamarrón; S Solís; S Jiménez-Alvarez
Journal:  Rev Esp Quimioter       Date:  2018-01-29       Impact factor: 1.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.